Immune response and possible therapeutics in COVID-19

6Citations
Citations of this article
34Readers
Mendeley users who have this article in their library.

Abstract

COVID-19 has emerged as a pandemic affecting about 213 countries in all the continents of the globe, resulting in more than 37.8 million individuals getting infected and over 1.08 million deaths worldwide, jeopardizing global human health and the economy. This presents an urgent need to develop therapies that target the SARS-CoV2 virus specifically. This review aims at presenting the available information on the coronavirus disease 2019 along with various drugs that are having widespread use until a vaccine candidate is available to aid in the development of therapeutic strategies against COVID-19. This journal is

Cite

CITATION STYLE

APA

Dutta, A., Roy, A., Roy, L., Chattopadhyay, S., & Chatterjee, S. (2020, November 24). Immune response and possible therapeutics in COVID-19. RSC Advances. Royal Society of Chemistry. https://doi.org/10.1039/d0ra08901j

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free